Published: October 2011
No. of Pages: 150
Price: $ 2995
Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. The decentralized testing market is experiencing growth faster than the diagnostic markets at large and over the long term will create opportunities for innovative companies.
Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with fastest growth, and infectious disease has surfaced as one of those segments. This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this segment, and especially new threats for which there are large markets in the developing world and in developed countries.
Browse All: Pharmaceuticals Market Research
An Opportunity For Test Makers
Infectious disease is a broad category, and in some disease areas, diagnostic companies already own market share. Increasingly hospitals and clinics are seeing new infectious disease threats and tests are being developed to assist them. Within the infectious disease testing market, this report details the opportunities that could be found when diseases of the developing world enter the healthcare system of the developed. This report provides market projections for point of care diagnostics in the developed and developing world for the following infectious diseases:
* Chagas Disease, Rapid Test Market Forecast to 2016
* Chikungunya, Rapid Test Market Forecast to 2016
* Dengue Fever, Rapid Test Market Forecast to 2016
* HIV, Rapid Test Market Current Size and Forecast to 2016
* HPV, Rapid Test Market Current Size and Forecast to 2016
* Leishmaniasis, Rapid Test Market Forecast to 2016
* Onchocerciasis (River Blindness), Rapid Test Market Forecast to 2016
* STDs, Rapid Test Market Current Size and Forecast to 2016
* Tuberculosis, Rapid Test Market Forecast to 2016
In addition the report also provides:
* The Overall Point of Care Diagnostics Market
* Economics of Financial and International Programs
* Company Profiles of Leaders in the POC Infectious Disease Market
* EMR and Connectivity Issues
* Tests in Development
* The Role of Drug Resistance
* Disease Statistics
Technical and Market Considerations
Many reports provide market projections, but those projections rely on the development of new tests which will enter the market. This report considers the technical factors behind product development. Tests for diseases can only be provided where the technical means to develop a test exist. This report also deals with the technical choices, possibilities and limitations to today's tests. Reagent issues, testing on strips, instrumented and non-instrumented tests. These factors will impact the tests that reach the market.
No comments:
Post a Comment